FDA tightens guidelines on technique for uterine fibroid surgery

November 24, 2014 4:12 PM

3 0

WASHINGTON (Reuters) - The U.S. Food and Drug Administration has tightened its guidelines on the use of a uterine surgical technique, saying it has been linked to the spread of a rare type of cancer.

The agency said on Monday it is recommending that a boxed warning be placed on laparoscopic power morcellator devices used to treat uterine fibroids. Such an FDA warning is the strongest that a medication or treatment can carry while still remaining on the U.S. market.

Read more

To category page